Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.5689
-0.0101-1.74%
Volume:753.24K
Turnover:427.33K
Market Cap:158.15M
PE:-1.14
High:0.5800
Open:0.5800
Low:0.5600
Close:0.5790
52wk High:2.55
52wk Low:0.5261
Shares:278.00M
Float Shares:245.00M
Volume Ratio:1.24
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:5.06
PE(LYR):-2.20

Loading ...

Humacyte - to File Supplemental Bla With FDA in Second Half of 2026

THOMSON REUTERS
·
Jun 11

Humacyte shareholders approve increase in authorized common shares to 550 million

Reuters
·
Jun 10

Humacyte Price Target Maintained With a $2.00/Share by BTIG

Dow Jones
·
Jun 08

Humacyte Is Maintained at Speculative Buy by Benchmark

Dow Jones
·
Jun 01

Humacyte price target raised to $2 from $1 at Benchmark

TIPRANKS
·
Jun 01

Humacyte Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
May 27

Humacyte announces presentation at VASA meeting on self-repair ATEV

TIPRANKS
·
May 26

Humacyte says interim Phase 3 dialysis access study results due June 11

Reuters
·
May 26

Humacyte director Kathleen Sebelius acquires 56,818 shares for $49,999.84

Reuters
·
May 21

Humacyte director Michael T. Constantino acquires common shares worth $9,840

Reuters
·
May 21

Humacyte Announces Symvess® Is NOW Under Contract With the Strategic Acquisition Center (Sac) of the U.S. Department of Veterans Affairs

THOMSON REUTERS
·
May 20

Press Release: Humacyte Announces Symvess(R) is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

Dow Jones
·
May 20

Humacyte (HUMA) Valuation Check As Q1 2026 Losses Meet Cost Cuts New Leadership And Global Agreements

Simply Wall St.
·
May 16

Humacyte Is Maintained at Buy by BTIG

Dow Jones
·
May 14

Humacyte Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Humacyte Q1 EPS $(0.09) Beats $(0.11) Estimate, Sales $495.000K Miss $1.455M Estimate

Benzinga Earnings
·
May 13

Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 13

Humacyte appoints Todd Rasmussen chief surgical officer

Reuters
·
May 12

Humacyte Appoints DR. Todd E. Rasmussen as Chief Surgical Officer

THOMSON REUTERS
·
May 12

Press Release: Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer

Dow Jones
·
May 12